Logo image of ASLE

AERSALE CORP (ASLE) Stock Fundamental Analysis

NASDAQ:ASLE - Nasdaq - US00810F1066 - Common Stock - Currency: USD

6.11  -0.02 (-0.33%)

After market: 6.11 0 (0%)

Fundamental Rating

3

Overall ASLE gets a fundamental rating of 3 out of 10. We evaluated ASLE against 67 industry peers in the Aerospace & Defense industry. ASLE has a bad profitability rating. Also its financial health evaluation is rather negative. ASLE is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ASLE had positive earnings in the past year.
ASLE had a negative operating cash flow in the past year.
Of the past 5 years ASLE 4 years were profitable.
The reported operating cash flow has been mixed in the past 5 years: ASLE reported negative operating cash flow in multiple years.
ASLE Yearly Net Income VS EBIT VS OCF VS FCFASLE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

ASLE has a worse Return On Assets (-0.88%) than 62.69% of its industry peers.
ASLE's Return On Equity of -1.40% is on the low side compared to the rest of the industry. ASLE is outperformed by 61.19% of its industry peers.
Industry RankSector Rank
ROA -0.88%
ROE -1.4%
ROIC N/A
ROA(3y)2.74%
ROA(5y)3.56%
ROE(3y)3.3%
ROE(5y)4.23%
ROIC(3y)N/A
ROIC(5y)N/A
ASLE Yearly ROA, ROE, ROICASLE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8

1.3 Margins

In the last couple of years the Profit Margin of ASLE has declined.
In the last couple of years the Operating Margin of ASLE has declined.
ASLE has a better Gross Margin (29.07%) than 68.66% of its industry peers.
ASLE's Gross Margin has declined in the last couple of years.
ASLE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 29.07%
OM growth 3Y-38.78%
OM growth 5YN/A
PM growth 3Y-45.72%
PM growth 5YN/A
GM growth 3Y-4.95%
GM growth 5YN/A
ASLE Yearly Profit, Operating, Gross MarginsASLE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

3

2. Health

2.1 Basic Checks

ASLE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ASLE has been increased compared to 1 year ago.
The number of shares outstanding for ASLE has been increased compared to 5 years ago.
ASLE has about the same debt/assets ratio as last year.
ASLE Yearly Shares OutstandingASLE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
ASLE Yearly Total Debt VS Total AssetsASLE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 1.97 indicates that ASLE is not a great score, but indicates only limited risk for bankruptcy at the moment.
ASLE has a worse Altman-Z score (1.97) than 71.64% of its industry peers.
ASLE has a Debt/Equity ratio of 0.33. This is a healthy value indicating a solid balance between debt and equity.
ASLE has a better Debt to Equity ratio (0.33) than 67.16% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF N/A
Altman-Z 1.97
ROIC/WACCN/A
WACC10.57%
ASLE Yearly LT Debt VS Equity VS FCFASLE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

A Current Ratio of 4.54 indicates that ASLE has no problem at all paying its short term obligations.
The Current ratio of ASLE (4.54) is better than 91.04% of its industry peers.
A Quick Ratio of 0.88 indicates that ASLE may have some problems paying its short term obligations.
ASLE's Quick ratio of 0.88 is on the low side compared to the rest of the industry. ASLE is outperformed by 70.15% of its industry peers.
Industry RankSector Rank
Current Ratio 4.54
Quick Ratio 0.88
ASLE Yearly Current Assets VS Current LiabilitesASLE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for ASLE have decreased strongly by -72.73% in the last year.
Measured over the past years, ASLE shows a very strong growth in Earnings Per Share. The EPS has been growing by 22.36% on average per year.
Looking at the last year, ASLE shows a decrease in Revenue. The Revenue has decreased by -7.63% in the last year.
ASLE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.45% yearly.
EPS 1Y (TTM)-72.73%
EPS 3Y-40.01%
EPS 5Y22.36%
EPS Q2Q%-145.45%
Revenue 1Y (TTM)-7.63%
Revenue growth 3Y0.45%
Revenue growth 5YN/A
Sales Q2Q%-27.35%

3.2 Future

The Earnings Per Share is expected to grow by 74.93% on average over the next years. This is a very strong growth
ASLE is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.59% yearly.
EPS Next Y-35.58%
EPS Next 2Y74.93%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.45%
Revenue Next 2Y8.59%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ASLE Yearly Revenue VS EstimatesASLE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M
ASLE Yearly EPS VS EstimatesASLE Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 203.67, ASLE can be considered very expensive at the moment.
ASLE's Price/Earnings ratio is a bit more expensive when compared to the industry. ASLE is more expensive than 61.19% of the companies in the same industry.
ASLE's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.03.
The Price/Forward Earnings ratio is 10.51, which indicates a very decent valuation of ASLE.
ASLE's Price/Forward Earnings ratio is rather cheap when compared to the industry. ASLE is cheaper than 100.00% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 36.28. ASLE is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 203.67
Fwd PE 10.51
ASLE Price Earnings VS Forward Price EarningsASLE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200

4.2 Price Multiples

ASLE's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ASLE is cheaper than 61.19% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 25.08
ASLE Per share dataASLE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

A more expensive valuation may be justified as ASLE's earnings are expected to grow with 74.93% in the coming years.
PEG (NY)N/A
PEG (5Y)9.11
EPS Next 2Y74.93%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ASLE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AERSALE CORP

NASDAQ:ASLE (8/5/2025, 8:00:00 PM)

After market: 6.11 0 (0%)

6.11

-0.02 (-0.33%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-06 2025-08-06/amc
Inst Owners51.82%
Inst Owner Change0.08%
Ins Owners8.6%
Ins Owner Change-445.02%
Market Cap286.31M
Analysts80
Price Target6.63 (8.51%)
Short Float %4.53%
Short Ratio4.92
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-79.82%
Min EPS beat(2)-157.67%
Max EPS beat(2)-1.96%
EPS beat(4)0
Avg EPS beat(4)-83.78%
Min EPS beat(4)-157.67%
Max EPS beat(4)-1.96%
EPS beat(8)1
Avg EPS beat(8)-60.01%
EPS beat(12)3
Avg EPS beat(12)-40.33%
EPS beat(16)7
Avg EPS beat(16)10.17%
Revenue beat(2)1
Avg Revenue beat(2)-13.38%
Min Revenue beat(2)-27.97%
Max Revenue beat(2)1.22%
Revenue beat(4)1
Avg Revenue beat(4)-13.17%
Min Revenue beat(4)-27.97%
Max Revenue beat(4)1.22%
Revenue beat(8)2
Avg Revenue beat(8)-16.53%
Revenue beat(12)3
Avg Revenue beat(12)-14.46%
Revenue beat(16)6
Avg Revenue beat(16)-7.92%
PT rev (1m)-13.33%
PT rev (3m)-18.75%
EPS NQ rev (1m)-53.85%
EPS NQ rev (3m)-66.67%
EPS NY rev (1m)0%
EPS NY rev (3m)-75.26%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.98%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-10.45%
Valuation
Industry RankSector Rank
PE 203.67
Fwd PE 10.51
P/S 0.89
P/FCF N/A
P/OCF N/A
P/B 0.7
P/tB 0.78
EV/EBITDA 25.08
EPS(TTM)0.03
EY0.49%
EPS(NY)0.58
Fwd EY9.52%
FCF(TTM)-0.54
FCFYN/A
OCF(TTM)-0.27
OCFYN/A
SpS6.84
BVpS8.67
TBVpS7.82
PEG (NY)N/A
PEG (5Y)9.11
Profitability
Industry RankSector Rank
ROA -0.88%
ROE -1.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 29.07%
FCFM N/A
ROA(3y)2.74%
ROA(5y)3.56%
ROE(3y)3.3%
ROE(5y)4.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-38.78%
OM growth 5YN/A
PM growth 3Y-45.72%
PM growth 5YN/A
GM growth 3Y-4.95%
GM growth 5YN/A
F-Score1
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF N/A
Debt/EBITDA 8.06
Cap/Depr 70.77%
Cap/Sales 4.02%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.54
Quick Ratio 0.88
Altman-Z 1.97
F-Score1
WACC10.57%
ROIC/WACCN/A
Cap/Depr(3y)91.07%
Cap/Depr(5y)58.73%
Cap/Sales(3y)3.18%
Cap/Sales(5y)2.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-72.73%
EPS 3Y-40.01%
EPS 5Y22.36%
EPS Q2Q%-145.45%
EPS Next Y-35.58%
EPS Next 2Y74.93%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-7.63%
Revenue growth 3Y0.45%
Revenue growth 5YN/A
Sales Q2Q%-27.35%
Revenue Next Year1.45%
Revenue Next 2Y8.59%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y70.55%
EBIT growth 3Y-38.5%
EBIT growth 5YN/A
EBIT Next Year323.88%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y77.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y88.1%
OCF growth 3Y-47.9%
OCF growth 5YN/A